Massimo Roncalli
Massimo Roncalli
Humanitas University
Verified email at
TitleCited byYear
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab
K Yonesaka, K Zejnullahu, I Okamoto, T Satoh, F Cappuzzo, J Souglakos, ...
Science translational medicine 3 (99), 99ra86-99ra86, 2011
Increased MET gene copy number negatively affects survival of surgically resected non–small-cell lung cancer patients
F Cappuzzo, A Marchetti, M Skokan, E Rossi, S Gajapathy, L Felicioni, ...
Journal of Clinical Oncology 27 (10), 1667, 2009
A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial
M Infante, S Cavuto, FR Lutman, G Brambilla, G Chiesa, G Ceresoli, ...
American journal of respiratory and critical care medicine 180 (5), 445-453, 2009
Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis
L Di Tommaso, G Franchi, YN Park, B Fiamengo, A Destro, E Morenghi, ...
Hepatology 45 (3), 725-734, 2007
Identifying and targeting ROS1 gene fusions in non–small cell lung cancer
KD Davies, AT Le, MF Theodoro, MC Skokan, DL Aisner, EM Berge, ...
Clinical Cancer Research 18 (17), 4570-4579, 2012
EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients
F Cappuzzo, G Finocchiaro, E Rossi, PA Jšnne, C Carnaghi, C Calandri, ...
Annals of Oncology 19 (4), 717-723, 2007
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients
F Cappuzzo, PA Jšnne, M Skokan, G Finocchiaro, E Rossi, C Ligorio, ...
Annals of oncology 20 (2), 298-304, 2008
Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib (‘Iressa’, ZD1839) in non-small-cell lung cancer
HS Parra, R Cavina, F Latteri, PA Zucali, E Campagnoli, E Morenghi, ...
British journal of cancer 91 (2), 208, 2004
The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma
L Di Tommaso, A Destro, JY Seok, E Balladore, L Terracciano, ...
Journal of hepatology 50 (4), 746-754, 2009
M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro
M Leidi, E Gotti, L Bologna, E Miranda, M Rimoldi, A Sica, M Roncalli, ...
The Journal of Immunology 182 (7), 4415-4422, 2009
Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study
M Borzio, S Bruno, M Roncalli, GC Mels, G Ramella, F Borzio, G Leandro, ...
Gastroenterology 108 (3), 812-817, 1995
Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development
M Borzio, S Fargion, F Borzio, AL Fracanzani, AM Croce, T Stroffolini, ...
Journal of hepatology 39 (2), 208-214, 2003
Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients
F Cappuzzo, M Varella-Garcia, G Finocchiaro, M Skokan, S Gajapathy, ...
British Journal of cancer 99 (1), 83, 2008
The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification
M Roncalli, E Roz, G Coggi, MG Di Rocco, P Bossi, E Minola, ...
Hepatology 30 (5), 1174-1178, 1999
Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia
International Consensus Group for Hepatocellular Neoplasia
Hepatology 49 (2), 658-664, 2009
Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer
A Malesci, L Laghi, P Bianchi, G Delconte, A Randolph, V Torri, ...
Clinical Cancer Research 13 (13), 3831-3839, 2007
p53 protein accumulation and p53 gene mutation in esophageal carcinoma: a molecular and immunohistochemical study with clinicopathologic correlations
G Coggi, S Bosari, M Roncalli, D Graziani, P Bossi, G Viale, R Buffa, ...
Cancer: Interdisciplinary International Journal of the American Cancer†…, 1997
p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma.
S Bosari, G Viale, M Roncalli, D Graziani, G Borsani, AK Lee, G Coggi
The American journal of pathology 147 (3), 790, 1995
CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study
L Laghi, P Bianchi, E Miranda, E Balladore, V Pacetti, F Grizzi, P Allavena, ...
The lancet oncology 10 (9), 877-884, 2009
Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples
D Baumhoer, L Tornillo, S Stadlmann, M Roncalli, EK Diamantis, ...
American journal of clinical pathology 129 (6), 899-906, 2008
The system can't perform the operation now. Try again later.
Articles 1–20